ProCE Banner Activity

Current Practice: Checkpoint Inhibitors in Unresectable Stage III NSCLC

Slideset Download
Download this slideset to review historical data for concurrent CRT compared to the latest clinical evidence for checkpoint inhibitor therapy in the care of patients with unresectable stage III NSCLC.

Released: November 08, 2018

Expiration: November 07, 2019

No longer available for credit.

Share

Faculty

Edward B. Garon

Edward B. Garon, MD, MS

Professor of Medicine
Director of Thoracic Oncology
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Edward B. Garon, MD, MS

Professor of Medicine
Director of Thoracic Oncology
David Geffen School of Medicine at UCLA
Los Angeles, California